The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
Chemical Compound Review

SureCN4066     17-(2-hydroxyethanoyl)-10,13- dimethyl-1,2...

Synonyms: NSC-11319, Oprea1_800194, NSC11319, CTK5C1784, STL069543, ...
 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of Deoxycorticosterone

 

High impact information on Deoxycorticosterone

 

Chemical compound and disease context of Deoxycorticosterone

 

Biological context of Deoxycorticosterone

 

Anatomical context of Deoxycorticosterone

 

Associations of Deoxycorticosterone with other chemical compounds

 

Gene context of Deoxycorticosterone

  • In conclusion, GCA and DOC have similar effects on CRF and beta EP containing neurons at the PVN [15].
  • Role of AVP in malignant DOC-salt hypertension: studies using vascular and antidiuretic antagonists [17].
 

Analytical, diagnostic and therapeutic context of Deoxycorticosterone

  • AVP-dependent Pf in CCD from rats on the low salt-diet, with or without DOC treatment, was also markedly lower [18].

References

  1. Role of extracellular volume expansion in the development of DOC-salt hypertension in the rat. Villamil, M.F., Amorena, C., Ponce-Hornos, J., Müller, A., Taquini, A.C. Hypertension (1982) [Pubmed]
  2. Steroid characteristics of mineralocorticoid adrenocortical hypertension. Biglieri, E.G., Kater, C.E. Clin. Chem. (1991) [Pubmed]
  3. Chronic effects of a beta-adrenoceptor blocking drug, 4-[3-(tert-butylamino)-2-hydroxypropoxy]-N-methylisocarbostyril hydrochloride (N-696), in hypertensive rats. Kubota, N., Kishi, K., Sokabe, H., Kawashima, K., Ishii, Y., Kawase, S. J. Pharmacobio-dyn. (1985) [Pubmed]
  4. The role of vasopressin in hypertension. Share, L., Crofton, J.T. Fed. Proc. (1984) [Pubmed]
  5. In vivo and in vitro studies on steroid metabolism in a case of primary aldosteronism with multiple lesions of adenoma and nodular hyperplasia. Honda, M., Tsuchiya, M., Tamura, H., Watanabe, H., Izumi, Y., Hatano, M., Shiratsuchi, T., Den, K., Kawaoi, A., Okano, T. Endocrinol. Jpn. (1982) [Pubmed]
  6. Renin-like activity in the rat brain during the development of DOC-salt hypertension. Basso, N., Ruiz, P., Mangiarua, E., Taquini, A.C. Hypertension (1981) [Pubmed]
  7. Evidence for an unidentified ACTH-induced steroid hormone causing hypertension. New, M.I., Peterson, R.E., Saenger, P., Levine, L.S. J. Clin. Endocrinol. Metab. (1976) [Pubmed]
  8. Hydration of rainbow trout oocyte during meiotic maturation and in vitro regulation by 17,20{beta}-dihydroxy-4-pregnen-3-one and cortisol. Milla, S., Jalabert, B., Rime, H., Prunet, P., Bobe, J. J. Exp. Biol. (2006) [Pubmed]
  9. Salt sensitivity of blood pressure in patients with 17 alpha-hydroxylase deficiency. Nagase, M., Ando, K., Fujita, T. Am. J. Hypertens. (1994) [Pubmed]
  10. Diurnal blood pressure variability in mineralocorticoid excess syndrome. White, W.B., Malchoff, C. Am. J. Hypertens. (1992) [Pubmed]
  11. Osmotic stimulation in DOC-salt hypertension: vasopressin and blood pressure. Crofton, J.T., Share, L., Brooks, D.P. J. Hypertens. (1986) [Pubmed]
  12. In vivo effects of thyroid hormone, corticosteroids and prolactin on cell proliferation and apoptosis in the anterior intestine of the euryhaline mudskipper (Periophthalmus modestus). Takahashi, H., Takahashi, A., Sakamoto, T. Life Sci. (2006) [Pubmed]
  13. Role of vasopressin, catecholamines, and plasma volume in hypertonic saline-induced hypertension. Hatzinikolaou, P., Gavras, H., Brunner, H.R., Gavras, I. Am. J. Physiol. (1981) [Pubmed]
  14. Increased Ca2+ in the sarcoplasm of aortic smooth muscle cells from rats made hypertensive with DOC. A quantitative ultrastructural and cytochemical study. Aguas, A.P., Nickerson, P.A. J. Submicrosc. Cytol. (1983) [Pubmed]
  15. Effects of glycyrrhizic acid and steroid treatment on corticotropin releasing factor and beta-endorphin containing neurons of the hypothalamus of the rat. Ruszymah, B.H., Nabishah, B.M., Aminuddin, S., Sarjit, S., Khalid, B.A. The Malaysian journal of pathology. (1999) [Pubmed]
  16. Differential effects of 3,4,5,3',4',5'-hexachlorobiphenyl (HCB) on interrenal steroidogenesis in male and female rainbow trout Oncorhynchus mykiss. Miranda, C.L., Henderson, M.C., Wang, J.L., Chang, H.S., Hendricks, J.D., Buhler, D.R. Comp. Biochem. Physiol. C, Comp. Pharmacol. Toxicol. (1992) [Pubmed]
  17. Role of AVP in malignant DOC-salt hypertension: studies using vascular and antidiuretic antagonists. Filep, J., Frölich, J.C., Földes-Filep, E. Am. J. Physiol. (1987) [Pubmed]
  18. Low Na+ diet inhibits Na+ and water transport response to vasopressin in rat cortical collecting duct. Schafer, J.A., Chen, L. Kidney Int. (1998) [Pubmed]
 
WikiGenes - Universities